What is the recommended timing and dose of Indocyanine Green (ICG) administration for optimal visualization of biliary structures during cholecystectomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Optimal Timing and Dosage of ICG for Biliary Visualization During Cholecystectomy

Indocyanine green (ICG) should be administered intravenously at a dose of 0.1 mg approximately 30 minutes before laparoscopic cholecystectomy for optimal visualization of biliary structures. 1

Timing of ICG Administration

  • ICG should be administered intravenously approximately 30 minutes before the surgical procedure begins to achieve optimal visualization of biliary structures 1
  • This timing allows for adequate hepatic uptake and biliary excretion of ICG, maximizing the bile duct-to-liver ratio (BLR) of fluorescence intensity 1
  • Administering ICG too early (several hours before surgery) may result in excessive background liver fluorescence, while administering it too late may not allow sufficient time for biliary excretion 2

Optimal Dosage

  • A low dose of 0.1 mg ICG administered intravenously 30 minutes before surgery provides the highest bile duct-to-liver ratio (BLR) before surgical dissection of the cystohepatic triangle 1
  • This dosage shows superior visualization of extrahepatic biliary structures compared to both lower (0.025 mg) and higher doses (0.25 mg, 2.5 mg) 1
  • Weight-based dosing at 0.0119 mg/kg administered one hour before surgery is an alternative approach that provides excellent visualization of the extrahepatic biliary tree 3
  • Traditional higher doses (2.5 mg) used in earlier studies result in excessive background liver fluorescence that can obscure biliary structures 2, 4

Alternative Administration Methods

  • Direct intrabiliary injection of ICG (via percutaneous transhepatic gallbladder drainage, gallbladder puncture, or endoscopic nasobiliary drainage) at a dosage of 0.025 mg can be considered in specific cases 5
  • Intrabiliary injection provides 100% visualization of biliary structures compared to 83.3% with intravenous injection, but requires additional invasive procedures 5

Clinical Benefits and Considerations

  • ICG fluorescence cholangiography is a useful adjunct for confirming biliary anatomy during laparoscopic cholecystectomy without the need for X-ray imaging 6, 5
  • The technique helps prevent bile duct injuries, which occur in 0.4% of elective and 0.8% of emergency laparoscopic cholecystectomies 6, 2
  • ICG cholangiography is particularly valuable in cases with difficult anatomy, acute cholecystitis, or when intraoperative cholangiography (IOC) cannot be used 6
  • While ICG cholangiography is promising, routine use to reduce bile duct injury rates is not yet recommended in guidelines (Grade 2C recommendation) 6

Pitfalls and Caveats

  • Excessive ICG dosage leads to significant background liver fluorescence that can obscure biliary structures rather than enhance visualization 1, 4
  • The optimal timing and dose may need adjustment in patients with impaired liver function, as ICG is primarily cleared by the liver 5
  • ICG cholangiography should be considered as an adjunct to, not a replacement for, the critical view of safety technique during laparoscopic cholecystectomy 6
  • ICG administration has a learning curve, and surgeons should be familiar with the technology and interpretation of fluorescent imaging 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.